Michael J. Haas
Science & Biotech Writer for Public Relations
Welcome
I am a freelance writer/independent contractor dba Capitoline Triad Media. I write articles and other materials that highlight the science, technology, thought leadership and accomplishments of my clients in the biotech, life sciences and healthcare sectors.
Who are my clients?
My clients are primarily PR agencies representing companies in biotech, life sciences and healthcare. I also work directly with biotech companies, academic institutes, non-profits and other organizations.
What do I write and/or help you produce?
- By-lined thought leadership articles for company executives and SMEs (ghostwriting)
- Earned media pitches
- Press releases
- MAT releases / sponsored content
- Messaging and narratives for your clients
- Presentation scripts (live or recorded)
- Articles about new scientific papers and projects (see Portfolio below)
- Scientific "primers" to support business development and team education
- And more...
Articles I've written on behalf of company executives and other clients have appeared in AuntMinnie, BioCentury, Bio-IT World, Bioprocess Online, Cell & Gene, Cell & Gene Therapy Insights, Citrograph, The Cornell Chronicle, DDNews, Diagnostic Imaging, Drug Development & Delivery, Drug Discovery Online, Fierce Healthcare, GENEDGE, In Vivo, MedCityNews, mobihealthnews, mrweb, Oncology Times, Onco'Zine, Outsourced Pharma, PharmaTimes , STAT and other media outlets, company blogs, and company LinkedIn profiles.
The topics of those articles have included: agbio, AI/machine learning, antibiotics, cancer, cell & gene therapies, corporate culture, diagnostics, digital therapeutics, drug discovery & development, hematology, immuno-oncology, infectious disease, manufacturing, medical imaging, plant science, rare diseases, regulatory affairs, and more.
Whether you're seeking a writer for an idea you already have, or need strategic input to develop and refine the idea before pursuing it, you've come to the right place.
What is my expertise?
I bring three main areas of experience to the table: the skills and insider's view I developed as a reporter and journalist in biotech media; longtime experience as a lab chemist in the pharmaceutical industry; and, above all, expert writing skills honed on a wide range of topics for more than 20 years.
How do I work?
With my triad of experience, I will develop a deep comprehension of the topic and key messages; identify the information, angles and topics that best showcase your key messages; and write articles that clearly and persuasively deliver those messages to your target audience.
What else can I do for you?
I am available to conduct interviews for Q&As, moderate scientific symposia and panel discussions; provide editing services, ranging from basic proofreading through full-fledged content and structural editing; and assist with media outreach.
Michael J. Haas
Science & Biotech Writer for Public Relations
About
After more than a decade as an analytical chemist and group leader in the pharmaceutical industry, I moved out of the lab and reinvented myself as a professional writer. Though not seamless, this transition wasn't too difficult because I had discovered my writing ability long before that, and honed it at every opportunity.
Eventually, I found myself in the world of biotech news, where for nearly 12 years I wrote and edited stories about innovative technology and drug development at one of the top trade publications in the biotech industry. Along the way, I developed collegial working relationships with some of the smartest and nicest PR agents in biotech and pharma, and had the privilege of interviewing many C-level executives and top scientists in the industry.
With this varied background and the encouragement and support of my family, friends and colleagues, I launched Capitoline Triad Media in December 2019.
However, despite my long-standing connections to the biopharma industry, my scope encompasses more than just that space. I've also written and/or edited content on such diverse topics as medieval history, historical fantasy, plant science, herbal medicine, nursing and psychology. And I continue to expand my range with every project.
I am also Treasurer of the Weare Historical Society,
Portfolio
Selected works
For clients:
Note that to protect the confidentiality of my clients, I cannot share links to the thought leadership articles I've (ghost)written.
Phosphate biosensors could lead to more efficient fertilizer usage. (Jul. 19, 2022)
The missing links: Finding function in lincRNAs. (Jul. 14, 2022)
Wild tomato genome will benefit domesticated cousins. (Jun. 24, 2022)
PROTAC targeted protein degraders: The past is prologue. Nature Reviews Drug Discovery (Jan. 18, 2022) (Writing & editorial support)
Genetic discoveries could improve spinach’s disease resistance and palatability. (Dec. 22, 2021) [also published in the Cornell Chronicle]
Secrets of quillwort photosynthesis could boost crop efficiency. (Nov. 3, 2021)
Newly discovered gene could help improve tomato flavor and shelf-life. (Oct. 11, 2021)
Designing on the Grid, Book III: Alphanumeric Patterns for Mosaic Scrapbooking. (Editor) (August 2021)
Fungi could manipulate bacteria to enrich soil with nutrients. (Apr. 2, 2021)
Gene discovery may help peaches tolerate climate stress. (Mar. 9, 2021) [also published in the Cornell Chronicle]
Designing on the Grid, Book II: Graphic Patterns for Mosaic Scrapbooking. (Editor) (January 2021)
Silk Road Contains Genomic Resources for Improving Apples. (Nov. 2, 2020) [also published in the Cornell Chronicle]
Designing on the Grid: Graphic Patterns for Mosaic Scrapbooking. (Editor) (August 2020)
Harnessing psyllid peptides to fight citrus greening disease. (Apr. 17, 2020)
Wallflowers and the butterflies that don't love them. (Apr. 10, 2020) [also published in the Cornell Chronicle]
Wallflowers could lead to new drugs (Apr. 8, 2020)
The Sinclair Method: Accountability instead of judgment. (Jan. 17, 2020)
Plants found to speak roundworm's language. (Jan. 10, 2020) [also published in the Cornell Chronicle]
Aspirin-like compounds could treat numerous human diseases. (Dec. 17, 2019)
The Sinclair Method: Applying effort in place of willpower. (Nov. 20, 2019)
For biotech trade publications:
Note that some of these articles are behind paywalls
Refuge: Receptive CAR checkpoints. BioCentury (2019)
Singling out ovarian cancer. BioCentury (2015)
Refertilizing endometriosis. BioCentury Innovations (2015)
The right culture. BioCentury Innovations (2015)
PTSD: Rewriting fearful memories. SciBX: Science-Business eXchange (2014)
MPS IIIA: Gene therapy for brain and body. SciBX (2013)
Revisiting adrenomedullin in pre-eclampsia. SciBX (2013)
Bettering China's biosimilars. BioCentury (2013)
Opioid REMS under gun. BioCentury (2012)
Targovax: Ras to the rescue. BioCentury (2012)
Getting around peripartum cardiomyopathy. SciBX (2012)
Rituxan: Re-energizing CFS. SciBX (2011)
Outside the box in Quebec. SciBX (2011)
Blocking brain tumor rebound. SciBX (2010)
Unlocking ketones. SciBX (2010)
BerGenBio: Controlling interference. BioCentury (2009)
Monkey see. SciBX (2009)
Paths of yeast assistance. SciBX (2008)
Truly boronic. SciBX (2008)
Scientific papers:
Positive-ion analysis of boropeptides by chemical ionization and liquid secondary ionization mass spectrometry. Analytical Chemistry (1999)
Fully automated exact mass measurements by high‐resolution electrospray ionization on a sector instrument. Rapid Communications in Mass Spectrometry (1999)